Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes

Immunology

Volumn 101, Issue 1, 2000, Pages 76-82

  Nakagawa, Y ^a   Takeshita, T ^a   Berzofsky, J A ^b   Takahashi, H ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENVELOPE PROTEIN; EPITOPE; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; VIRUS ENVELOPE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIGEN PRESENTATION; BREFELDIN A; CAPTOPRIL; CELL CULTURE TECHNIQUES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; EXTRACELLULAR SPACE; HIV ENVELOPE PROTEIN GP160; HUMANS; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033801904     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00092.x     Document Type: Article

References (25)

1. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
2. b molecule
3. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
4. The ins and outs of antigen processing and presentation
5. Peptides naturally presented by MHC class I molecules
6. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes
7. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein
8. +cytotoxic T lymphocytes by peptide and purified cell-free class I molecules
9. Molecular analysis of the same HIV peptide fuctionally binding to both a class I and a class II MHC molecule
10. Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus I gp160 peptide for presentation by major histocompatibility complex class I molecules
11. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter
12. Peptide size selection by the major histocompatibility complex-encoded peptide transporter
13. Processing of major histocompatibility c ass I-restricted antigens in the endoplasmic reticulum
14. Trimming of antigenic peptides in an early secretory compartment
15. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes
16. Expression of the HTLV-III envelope gene by a recombinant vaccinia virus
17. Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides
18. Angiotensin I converting enzyme from human plasma
19. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids
20. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes
21. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing
22. Cellular peptide composition governed by major histocompatibility complex class I molecules
23. + cytotoxic T lymphocytes by free antigenic peptide: A self-veto mechanism?
24. Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides
25. Expression and characterization of recombinant human angiotensin I-converting enzyme